Reduction of syndecan-1 expression is associated with dysplastic oral epithelium
- PMID: 10947246
- DOI: 10.1034/j.1600-0714.2000.290704.x
Reduction of syndecan-1 expression is associated with dysplastic oral epithelium
Abstract
Syndecans are a family of integral membrane proteoglycans that participate in cell-matrix interactions and growth factor binding. Syndecan-1 expression is induced during keratinocyte differentiation and reduced in squamous cell carcinomas. The purpose of this study was to examine the alteration in syndecan-1 expression in dysplastic oral epithelium. Sixty-six oral biopsy specimens (43 epithelial dysplasias, 3 carcinoma in situ and 20 squamous cell carcinomas) were studied using immunohistochemical methods. The normal epithelium specimens were highly positive for syndecan-1. Fifteen of 46 dysplasias or carcinoma in situ specimens showed negative or weak staining for syndecan-1, two of which were totally negative. Intermediate and strong staining were observed in 17 and 14 dysplasias or carcinoma in situ specimens, respectively. Thirteen (65%) squamous cell carcinomas showed negative or weak staining for syndecan-1, seven of which were totally negative. Only three carcinomas had a strong syndecan-1 expression. Four of the 34 patients with dysplasia who were followed up developed squamous cell carcinoma. All these dysplasias had weak or totally negative syndecan-1 expression. The results suggest that the loss of syndecan-1 is associated with dysplastic changes in oral epithelium.
Similar articles
-
Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.J Oral Pathol Med. 2003 Oct;32(9):513-21. doi: 10.1034/j.1600-0714.2003.00117.x. J Oral Pathol Med. 2003. PMID: 12969225
-
Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.J Oral Pathol Med. 2006 May;35(5):301-6. doi: 10.1111/j.1600-0714.2006.00412.x. J Oral Pathol Med. 2006. PMID: 16630294
-
Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.Mod Pathol. 2003 Aug;16(8):796-801. doi: 10.1097/01.MP.0000081731.17549.53. Mod Pathol. 2003. PMID: 12920224
-
The role of syndecan-1 in malignancies.Ann Med. 1996 Feb;28(1):63-7. doi: 10.3109/07853899608999076. Ann Med. 1996. PMID: 8932508 Review.
-
Syndecan-1 in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1272:39-53. doi: 10.1007/978-3-030-48457-6_3. Adv Exp Med Biol. 2020. PMID: 32845501 Review.
Cited by
-
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.BMC Cancer. 2015 May 3;15:352. doi: 10.1186/s12885-015-1336-4. BMC Cancer. 2015. PMID: 25935541 Free PMC article.
-
Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis.Dent Res J (Isfahan). 2013 May;10(3):321-7. Dent Res J (Isfahan). 2013. PMID: 24019799 Free PMC article.
-
Syndecans in tumor cell adhesion and signaling.Reprod Biol Endocrinol. 2004 Jan 7;2:3. doi: 10.1186/1477-7827-2-3. Reprod Biol Endocrinol. 2004. PMID: 14711376 Free PMC article. Review.
-
New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.J Mol Histol. 2004 Mar;35(3):319-26. doi: 10.1023/b:hijo.0000032363.78829.4e. J Mol Histol. 2004. PMID: 15339051 Review.
-
Detection of Micro-invasion in Sudanese Oral Verrucous Carcinoma Samples Using Syndecan-1 Stain.Biomark Cancer. 2019 Sep 16;11:1179299X19861957. doi: 10.1177/1179299X19861957. eCollection 2019. Biomark Cancer. 2019. PMID: 31555051 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous